Friday, April 24, 2026 | 06:07 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Glenmark Pharmaceuticals Ltd

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 By Glenmark Pharmaceuticals Limited (GPL) In Respect Of Incorporation Of A Wholly Owned Subsidiary Company

05:38 PM, 13th May 2023

Pursuant to the provisions of Regulation 30 of SEBI Listing Regulations we wish to inform you that a wholly-owned subsidiary company of GPL in the name of Glenmark Healthcare Limited has been incorporated on May 12 2023 under corporate identity number U21001MH2023PLC402796 (WOS).The details/disclosures in respect of the said WOS as required under Regulation 30 of the SEBI Listing Regulations read with Schedule III thereto and the SEBI Circular No.CIR/CFD/CMD/4/2015 dated September 9 2015 are provided in the enclosed Annexure.

More Glenmark Pharmaceuticals Ltd Announcements